Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Fiz

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|December 6, 2014
Added prognostic value of ischaemic threshold in radionuclide myocardial perfusion imaging: a common-sense integration of exercise tolerance and ischaemia severityCecilia Marini, Wanda Acampa, Matteo Bauckneht, et al.
European Thyroid Journal|January 10, 2025
[18F]Tetrafluoroborate, a new NIS PET/CT radiopharmaceutical: an overview focused on differentiated thyroid cancerArnoldo Piccardo, Francesco Fiz, Sergio Righi, et al.
Bioengineering (Basel, Switzerland)|August 1, 2018
Assessment of Skeletal Tumor Load in Metastasized Castration-Resistant Prostate Cancer Patients: A Review of Available Methods and an Overview on Future PerspectivesFrancesco Fiz, Helmut Dittman, Cristina Campi, et al.
Pharmaceuticals (Basel, Switzerland)|April 26, 2025
Low-Dose Versus Standard-Dose Radioiodine Therapy in Differentiated Thyroid Cancer: Focus on Tolerability in a Retrospective EvaluationLaura Musso, Cristina Maltese, Giulio Beretta, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2015
Baseline and ongoing PET-derived factors predict detrimental effect or potential utility of 18F-FDG PET/CT (FDG-PET/CT) performed for surveillance in asymptomatic lymphoma patients in first remissionSilvia Morbelli, Selene Capitanio, Fabrizio De Carli, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 23, 2015
Contrast-enhanced [18 F] fluorodeoxyglucose-positron emission tomography/computed tomography in clinical oncology: tumor-, site-, and question-based comparison with standard positron emission tomography/computed tomographySilvia Morbelli, Raffaella Conzi, Claudio Campus, et al.
Radiology|March 6, 2014
Adult advanced chronic lymphocytic leukemia: computational analysis of whole-body CT documents a bone structure alterationFrancesco Fiz, Cecilia Marini, Roberta Piva, et al.
The International Journal of Cardiovascular Imaging|December 10, 2013
Divergent determinants of 18F-NaF uptake and visible calcium deposition in large arteries: relationship with Framingham risk scoreSilvia Morbelli, Francesco Fiz, Arnoldo Piccardo, et al.
Cancers|June 28, 2023
PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the LiteratureLaura Evangelista, Francesco Fiz, Riccardo Laudicella, et al.
Medicina (Kaunas, Lithuania)|July 2, 2021
To Enhance or Not to Enhance? The Role of Contrast Medium <sup>18</sup>F-FDG PET/CT in Recurrent Ovarian CarcinomasMichela Massollo, Francesco Fiz, Gianluca Bottoni, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
European Journal of Nuclear Medicine and Molecular Imaging|December 6, 2014
Added prognostic value of ischaemic threshold in radionuclide myocardial perfusion imaging: a common-sense integration of exercise tolerance and ischaemia severityCecilia Marini, Wanda Acampa, Matteo Bauckneht, et al.
European Thyroid Journal|January 10, 2025
[18F]Tetrafluoroborate, a new NIS PET/CT radiopharmaceutical: an overview focused on differentiated thyroid cancerArnoldo Piccardo, Francesco Fiz, Sergio Righi, et al.
Bioengineering (Basel, Switzerland)|August 1, 2018
Assessment of Skeletal Tumor Load in Metastasized Castration-Resistant Prostate Cancer Patients: A Review of Available Methods and an Overview on Future PerspectivesFrancesco Fiz, Helmut Dittman, Cristina Campi, et al.
Pharmaceuticals (Basel, Switzerland)|April 26, 2025
Low-Dose Versus Standard-Dose Radioiodine Therapy in Differentiated Thyroid Cancer: Focus on Tolerability in a Retrospective EvaluationLaura Musso, Cristina Maltese, Giulio Beretta, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2015
Baseline and ongoing PET-derived factors predict detrimental effect or potential utility of 18F-FDG PET/CT (FDG-PET/CT) performed for surveillance in asymptomatic lymphoma patients in first remissionSilvia Morbelli, Selene Capitanio, Fabrizio De Carli, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 23, 2015
Contrast-enhanced [18 F] fluorodeoxyglucose-positron emission tomography/computed tomography in clinical oncology: tumor-, site-, and question-based comparison with standard positron emission tomography/computed tomographySilvia Morbelli, Raffaella Conzi, Claudio Campus, et al.
Radiology|March 6, 2014
Adult advanced chronic lymphocytic leukemia: computational analysis of whole-body CT documents a bone structure alterationFrancesco Fiz, Cecilia Marini, Roberta Piva, et al.
The International Journal of Cardiovascular Imaging|December 10, 2013
Divergent determinants of 18F-NaF uptake and visible calcium deposition in large arteries: relationship with Framingham risk scoreSilvia Morbelli, Francesco Fiz, Arnoldo Piccardo, et al.
Cancers|June 28, 2023
PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the LiteratureLaura Evangelista, Francesco Fiz, Riccardo Laudicella, et al.
Medicina (Kaunas, Lithuania)|July 2, 2021
To Enhance or Not to Enhance? The Role of Contrast Medium <sup>18</sup>F-FDG PET/CT in Recurrent Ovarian CarcinomasMichela Massollo, Francesco Fiz, Gianluca Bottoni, et al.
Pageof 10